思特威(688213) - 2022 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2022 was ¥644,856,141.99, a decrease of 18.94% year-over-year[4] - The net profit attributable to shareholders for Q3 2022 was -¥46,634,705.75, representing a decline of 133.14% compared to the same period last year[4] - The basic earnings per share for Q3 2022 was -¥0.12, a decrease of 130.77% compared to the same period last year[5] - The diluted earnings per share for Q3 2022 was also -¥0.12, reflecting a similar decline of 130.77% year-over-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2022 was -¥77,553,683.01, down 155.04% year-over-year[4] - The company experienced a 19% year-over-year decline in sales revenue, attributed to market demand fluctuations and the pandemic[9] - Total operating revenue for Q3 2022 was ¥1,654,477,550.32, a decrease of 19% compared to ¥2,042,657,334.71 in Q3 2021[23] - The company's total liabilities amounted to ¥2,836,608,570.01, an increase from ¥1,761,515,776.48 year-over-year[21] - The net profit for Q3 2022 was -41,658,963.55 RMB, compared to a net profit of 320,456,470.40 RMB in Q3 2021, representing a significant decline[24] - The total comprehensive income for Q3 2022 was -40,339,016.60 RMB, down from 318,292,066.39 RMB in the same period last year[25] - The company's operating profit for Q3 2022 was -66,396,425.37 RMB, compared to an operating profit of 381,310,419.81 RMB in Q3 2021[24] Research and Development - The R&D investment for Q3 2022 totaled ¥98,098,124.21, an increase of 89.57% year-over-year, accounting for 15.21% of operating revenue[5] - Research and development expenses for Q3 2022 were ¥223,358,656.88, compared to ¥133,718,983.75 in Q3 2021, reflecting a significant increase[23] - The company plans to continue investing in new technologies and products to strengthen its market position despite current losses[9] - The company is focused on expanding its market presence and developing new technologies[18] Assets and Liabilities - The total assets at the end of Q3 2022 were ¥6,623,424,192.10, reflecting a 50.88% increase from the end of the previous year[5] - The equity attributable to shareholders at the end of Q3 2022 was ¥3,786,815,622.09, up 44.08% year-over-year due to funds raised from the IPO[11] - Total current assets reached ¥5,582,949,475.18, compared to ¥2,919,872,648.01 in the previous year[19] - Short-term borrowings increased significantly to ¥1,825,492,372.19 from ¥823,198,093.87 year-over-year[21] - Non-current liabilities totaled ¥553,593,143.80, up from ¥339,970,005.94 in the previous year[21] - The company's equity attributable to shareholders was ¥3,786,815,622.09, up from ¥2,628,356,802.10 in the previous year[21] Cash Flow - The cash flow from operating activities for the first three quarters of 2022 was -1,662,465,263.77 RMB, compared to -950,226,358.73 RMB in the first three quarters of 2021[27] - Cash inflow from operating activities totaled 1,522,875,040.13 RMB, while cash outflow was 3,185,340,303.90 RMB, resulting in a net cash flow deficit[27] - The company reported cash inflow from financing activities of 3,726,736,611.88 RMB, with a net cash flow from financing activities of 2,174,326,924.95 RMB[28] - The cash and cash equivalents at the end of Q3 2022 amounted to 1,183,573,810.75 RMB, an increase from 802,839,226.67 RMB at the end of Q3 2021[28] - The company reported cash inflow from investment activities of 10,742,000.00 RMB, while cash outflow was 107,233,652.61 RMB, resulting in a net cash flow deficit from investment activities[27] Shareholder Information - Total number of common shareholders at the end of the reporting period was 6,032[12] - The largest shareholder, Xu Chen, holds 54,828,443 shares, representing 13.71% of total shares[12] - The top ten shareholders collectively hold significant stakes, with the largest being 13.71%[12] - There are no significant changes in the status of pledged, marked, or frozen shares among major shareholders[12] - The company has no reported participation in margin financing or securities lending by the top shareholders[16]